Filter by
Filters
Filter results

Date

Campaigns

All campaigns

Report series

All publications

Miscellaneous

All miscellaneous
12 results found
Press release |

MSF responds to news that Gavi will release funds from pneumonia vaccine ‘Advance Market Commitment’ to first new product from a developing country manufacturer

Gavi, the Vaccine Alliance, has just announced that it will award part (US$75 million) of the remaining $262 million of the Advance Market Commitment (AMC)—a $1.5 billion fund that was launched in 2009 to pay for the introduction of ...
Blog |
26 January 2020

‘Medicines for the Many’

Whenever the topic of high medicine prices comes up, discussions often get very technical — buzzwords like ‘R&D costs’, ‘fair return on investment’ and ‘incentives’ are immediately thrown around.

While these terms come naturally to self-identifying policy geeks like me and we know the importance of these discussions, they risk blocking out the far bigger picture: the lives of patients.

Thankfully, every once in a while, a patient comes along to remind us and decision makers that while we debate the details of the perfect way to pay for medicines and conduct research and development, the status quo kills.